• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纤维肌发育不良的高血压患者中,肾内血流与肾功能和靶器官损害的关系:ARCADIA-POL 研究。

Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA-POL study.

机构信息

Department of Hypertension, Institute of Cardiology, Warsaw, Poland

2nd Department of Radiology, Medical University of Warsaw, Warsaw, Poland

出版信息

Pol Arch Intern Med. 2019 Apr 30;129(4):234-241. doi: 10.20452/pamw.4479. Epub 2019 Mar 7.

DOI:10.20452/pamw.4479
PMID:31038477
Abstract

INTRODUCTION Data on the assessment of intrarenal blood flow parameters in patients with renal fibromuscular dysplasia (FMD) are scarce. OBJECTIVES The aim of the study was to evaluate intrarenal blood flow parameters in patients with FMD and significant or nonsignificant renal artery stenosis (RAS). PATIENTS AND METHODS We evaluated intrarenal blood flow parameters by Doppler ultrasonography in 153 patients with renal FMD enrolled in the ARCADIA‑POL study: 32 and 121 patients with and without significant RAS, respectively, compared with 60 matched patients with essential hypertension and 60 healthy controls. RESULTS Patients with FMD and significant RAS had a lower renal resistive index (RRI) compared with patients with FMD without significant RAS, patients with essential hypertension, and normotensive controls (mean [SD], 0.51 [0.08] vs 0.60 [0.07], 0.62 [0.06], and 0.61 [0.06], respectively; P <0.001). In patients with nonsignificant RAS, RRI correlated significantly with carotid intima-media thickness, 24‑hour diastolic blood pressure, 24‑hour pulse pressure, left ventricular diastolic function, known duration time of hypertension, and age. In patients with significant RAS, there was a significant correlation between RRI and known duration time of hypertension, left ventricular diastolic function, and age. In a separate, "per‑kidney" analysis, renal arteries with FMD and significant RAS were characterized by lower RRI values, higher maximal blood flow velocity, higher renal aortic ratio, and longer acceleration time compared with renal arteries with FMD and nonsignificant RAS as well as renal arteries without FMD. CONCLUSIONS In contrast to atherosclerotic RAS, intrarenal blood flow in patients with FMD and RAS is preserved, confirming that renal vasculature is relatively intact in these patients.

摘要

简介

关于肾血管平滑肌脂肪瘤(FMD)患者肾内血流参数评估的数据很少。

目的

本研究旨在评估 FMD 伴或不伴显著肾动脉狭窄(RAS)患者的肾内血流参数。

患者与方法

我们通过多普勒超声评估了 ARCADIA-POL 研究中的 153 例 FMD 患者的肾内血流参数:32 例和 121 例患者分别伴有和不伴有显著 RAS,并与 60 例原发性高血压患者和 60 例健康对照者进行了比较。

结果

与不伴有显著 RAS 的 FMD 患者、原发性高血压患者和血压正常的对照组相比,伴有显著 RAS 的 FMD 患者的肾阻力指数(RRI)较低(均值[标准差]:0.51[0.08] vs. 0.60[0.07]、0.62[0.06]和 0.61[0.06];P<0.001)。在不伴有显著 RAS 的患者中,RRI 与颈动脉内膜中层厚度、24 小时舒张压、24 小时脉压、左心室舒张功能、已知高血压持续时间和年龄显著相关。在伴有显著 RAS 的患者中,RRI 与已知高血压持续时间、左心室舒张功能和年龄之间存在显著相关性。在单独的“每肾”分析中,与肾内 FMD 和不伴显著 RAS 的肾动脉以及无 FMD 的肾动脉相比,伴有 FMD 和显著 RAS 的肾动脉的 RRI 值较低、最大血流速度较高、肾主动脉比值较高、加速时间较长。

结论

与动脉粥样硬化性 RAS 相反,FMD 伴 RAS 的患者肾内血流得以保留,这证实了这些患者的肾血管相对完整。

相似文献

1
Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA-POL study.在纤维肌发育不良的高血压患者中,肾内血流与肾功能和靶器官损害的关系:ARCADIA-POL 研究。
Pol Arch Intern Med. 2019 Apr 30;129(4):234-241. doi: 10.20452/pamw.4479. Epub 2019 Mar 7.
2
Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.多灶性肾动脉纤维肌发育不良患者的肾血流动力学和肾素-血管紧张素系统活性
J Hypertens. 2016 Jun;34(6):1160-9. doi: 10.1097/HJH.0000000000000917.
3
Doppler indexes of left ventricular systolic and diastolic flow and central pulse pressure in relation to renal resistive index.左心室收缩和舒张血流的多普勒指数以及中心脉压与肾阻力指数的关系。
Am J Hypertens. 2015 Apr;28(4):535-45. doi: 10.1093/ajh/hpu185. Epub 2014 Sep 20.
4
Echocardiographic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia: the ARCADIA-POL study.纤维肌性发育不良患者左心室形态和功能的超声心动图评估:ARCADIA-POL 研究。
J Hypertens. 2018 Jun;36(6):1318-1325. doi: 10.1097/HJH.0000000000001706.
5
Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients.大量高血压患者的肾阻力指数与心血管器官损害
J Hum Hypertens. 2007 Apr;21(4):291-6. doi: 10.1038/sj.jhh.1002145. Epub 2007 Jan 25.
6
Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia.肾动脉纤维肌发育不良经皮腔内血管成形术的长期随访
Int Angiol. 2015 Dec;34(6):529-37. Epub 2014 May 13.
7
High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia).纤维肌发育不良患者的多发性动脉床病变发生率较高:ARCADIA 登记研究(评估肾和颈动脉发育不良)。
Hypertension. 2017 Sep;70(3):652-658. doi: 10.1161/HYPERTENSIONAHA.117.09539. Epub 2017 Jul 17.
8
Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis.多灶性纤维肌发育不良与动脉粥样硬化性肾动脉狭窄之间的病理生理差异。
J Hypertens. 2017 Apr;35(4):845-852. doi: 10.1097/HJH.0000000000001243.
9
Renal Ultrasound (and Doppler Sonography) in Hypertension: An Update.高血压的肾脏超声检查(及多普勒超声检查):最新进展
Adv Exp Med Biol. 2017;956:191-208. doi: 10.1007/5584_2016_170.
10
Prevalence of smoking and clinical characteristics in fibromuscular dysplasia. The ARCADIA-POL study.纤维肌发育异常中吸烟的患病率及临床特征。ARCADIA-POL研究。
Blood Press. 2019 Feb;28(1):49-56. doi: 10.1080/08037051.2018.1514252. Epub 2018 Dec 18.

引用本文的文献

1
Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.成人纤维肌发育不良的临床、分子和遗传方面的最新进展。
Cardiovasc Res. 2022 Jan 7;118(1):65-83. doi: 10.1093/cvr/cvab086.
2
Fibromuscular dysplasia and hypertension-a statement on behalf of the British and Irish Hypertension Society.纤维肌发育不良与高血压——代表英国和爱尔兰高血压学会发表的声明
J Hum Hypertens. 2021 Nov;35(11):1051-1053. doi: 10.1038/s41371-020-00456-6. Epub 2020 Dec 1.